£495.00

It has never been this cheap. We have no record of a lower price.

£495 today · cheaper than every other day in the last 3 months

2023-2028 Hypercalcemia Treatment Outlook for China

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 38 days · 38 data points (no recent data)

Historical
Generating forecast…
£495.00 £470.25 £480.15 £490.05 £499.95 £509.85 £519.75 22 August 2026 31 August 2026 09 September 2026 18 September 2026 28 September 2026
View at Amazon ↗

Price data last checked 53 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 38 days • 1 price levels

Days at Price
38 days 0 10 19 29 38 £495 Days at Price

Price Analysis

Most common price: £495 (38 days, 100.0%)

Price range: £495 - £495

Price levels: 1 different prices over 38 days

Description

This comprehensive market research report analyses the latent demand outlook for hypercalcemia treatments across all regions of China, including provinces, autonomous regions, municipalities, special administrative regions, and Taiwan. The study provides potential industry earnings (P.I.E.) estimates spanning approximately 1,100 cities throughout China, with detailed regional breakdowns showing each major city's percentage share relative to its province and to China as a whole. The report delivers strategic insights into market opportunities and demand patterns for hypercalcemia treatment products and services across the Chinese healthcare landscape, making it essential for pharmaceutical companies, healthcare providers, and market analysts planning distribution strategies and investment decisions in this critical therapeutic area.

Key Features

Covers latent demand forecasts for hypercalcemia treatments across all Chinese regions including provinces, autonomous regions, municipalities, and special administrative regions plus Taiwan.

Provides potential industry earnings (P.I.E.) estimates for approximately 1,100 cities throughout China to identify high-opportunity markets.

Includes regional analysis showing each major city's percentage share of provincial and national demand.

Spans the 2023-2028 outlook period, enabling five-year strategic planning for pharmaceutical and healthcare organisations.

Published by ICON Group International, Inc., a recognised source for market research and demand forecasting reports.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
16 August 2022
Listed Since
26 August 2022

Similar Products You Might Like

The 2023-2028 Outlook for Hypercalcemia Treatments in India
95% match

The 2023-2028 Outlook for Hypercalcemia Treatments in India

£515.00 27 Sep 2026
The 2023-2028 Outlook for Osteoporosis Treatments in India
88% match

The 2023-2028 Outlook for Osteoporosis Treatments in India

£515.00 27 Sep 2026
The 2016-2021 Outlook for Calcium Supplements in Greater China
88% match

The 2016-2021 Outlook for Calcium Supplements in Greater China

£595.00 28 Sep 2026
The 2023-2028 Outlook for Pet Veterinary Drugs in China
87% match

The 2023-2028 Outlook for Pet Veterinary Drugs in China

£495.00 15 Sep 2026
The 2027-2032 World Outlook for Calcium D-Glucarate
87% match

The 2027-2032 World Outlook for Calcium D-Glucarate

£890.00 22 Sep 2026
The 2023-2028 Outlook for Calcium and Vitamin D Supplements in India
86% match

The 2023-2028 Outlook for Calcium and Vitamin D Supplements in India

£515.00 27 Sep 2026
The 2023-2028 Outlook for Hepatitis Therapeutics in the United States
86% match

The 2023-2028 Outlook for Hepatitis Therapeutics in the United States

£520.00 27 Sep 2026
The 2023-2028 Outlook for Vitamin Deficiency Treatments for US Zip Codes
86% match

The 2023-2028 Outlook for Vitamin Deficiency Treatments for US Zip Codes

£490.00 27 Sep 2026
The 2019-2024 Outlook for Sun Care Products in China
86% match

The 2019-2024 Outlook for Sun Care Products in China

£446.25 27 Sep 2026
The 2023-2028 Outlook for Diabetic Nephropathy Treatments in India
86% match

The 2023-2028 Outlook for Diabetic Nephropathy Treatments in India

£515.00 27 Sep 2026
The 2023-2028 Outlook for Pharmaceuticals for US Zip Codes
85% match

The 2023-2028 Outlook for Pharmaceuticals for US Zip Codes

£490.00 27 Sep 2026
The 2023-2028 Outlook for Pruritus Corticosteroid Therapeutics in India
85% match

The 2023-2028 Outlook for Pruritus Corticosteroid Therapeutics in India

£515.00 27 Sep 2026
The 2016-2021 Outlook for Pharmaceutical Preparations for Human Use Affecting Neoplasms, the Endocrine System, and Metabolic Diseases in Greater China
85% match

The 2016-2021 Outlook for Pharmaceutical Preparations for Human Use Affecting Neoplasms, the Endocrine System, and Metabolic Diseases in Greater China

£595.00 28 Sep 2026
The 2023-2028 Outlook for Rheumatology Therapeutics in India
85% match

The 2023-2028 Outlook for Rheumatology Therapeutics in India

£515.00 27 Sep 2026
The 2023-2028 Outlook for Cystic Fibrosis Therapeutics for US Zip Codes
85% match

The 2023-2028 Outlook for Cystic Fibrosis Therapeutics for US Zip Codes

£490.00 27 Sep 2026
The 2023-2028 Outlook for Atrophic Scars Treatments for US Zip Codes
85% match

The 2023-2028 Outlook for Atrophic Scars Treatments for US Zip Codes

£490.00 27 Sep 2026
The 2023-2028 Outlook for Hyperhidrosis Treatments for US Zip Codes
85% match

The 2023-2028 Outlook for Hyperhidrosis Treatments for US Zip Codes

£490.00 27 Sep 2026
The 2023-2028 Outlook for Chronic Disease Management Therapeutics and Device Technologies in the United States
85% match

The 2023-2028 Outlook for Chronic Disease Management Therapeutics and Device Technologies in the United States

£520.00 27 Sep 2026
The 2023-2028 Outlook for Cushing's Syndrome Diagnostics and Treatments in the United States
85% match

The 2023-2028 Outlook for Cushing's Syndrome Diagnostics and Treatments in the United States

£520.00 29 Sep 2026
The 2023-2028 Outlook for Anti-Viral Nucleotide Polymerase Inhibitor Drugs in the United States
85% match

The 2023-2028 Outlook for Anti-Viral Nucleotide Polymerase Inhibitor Drugs in the United States

£520.00 27 Sep 2026
The 2023-2028 Outlook for Thyroid Gland Disorders in India
85% match

The 2023-2028 Outlook for Thyroid Gland Disorders in India

£515.00 27 Sep 2026
The 2023-2028 Outlook for Antifungal Drugs in India
85% match

The 2023-2028 Outlook for Antifungal Drugs in India

£515.00 27 Sep 2026
The 2023-2028 Outlook for Amino Acid Metabolism Disorders Treatments in the United States
85% match

The 2023-2028 Outlook for Amino Acid Metabolism Disorders Treatments in the United States

£520.00 27 Sep 2026
The 2023-2028 Outlook for Atrophic Scars Treatments in the United States
85% match

The 2023-2028 Outlook for Atrophic Scars Treatments in the United States

£520.00 27 Sep 2026